top of page
Search

Interview of Michael Chan for RTHK

RTHK came to C2i to ask Dr Michael Chan questions about his recent breakthrough study on Simeprevir as a potent treatment for COVID19.

Comments

  • Threads
  • YouTube
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter X logo round

CONTACT

Centre for Immunology & Infection Limited

免疫與感染研究中心有限公司

Unit 1111-1113, 11/F, Building 17W, 17 Science Park West Avenue

Hong Kong Science Park, Shatin, New Territories, Hong Kong    

香港新界沙田香港科學園科技大道西17W 11樓 1111-1113室

​​

Tel: +852 3910 3998

Fax: +852 3910 3670

​info@c2i.hk

  • Threads
  • Youtube
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter X white

©2023 Centre for Immunology & Infection Limited

bottom of page